Torax Medical, Inc.

Torax Medical, Inc. is a clinical stage medical device company based in Shoreview, Minnesota, founded in 2002. The company focuses on developing innovative implantable devices for treating digestive diseases, particularly gastroesophageal reflux disease (GERD) and fecal incontinence. Torax Medical is known for its commitment to advancing minimally invasive surgical treatments that enhance patient outcomes and quality of life. The company's flagship product, the LINX Reflux Management System, is designed to treat GERD. It features a small band of interlinked titanium beads that help prevent acid reflux by reinforcing the natural barrier between the stomach and esophagus. Additionally, the Fenix Continence Restoration System is an FDA-approved implant that addresses fecal incontinence by strengthening weak sphincter muscles. Torax Medical targets healthcare providers, including surgeons and gastroenterologists, in the U.S. and Europe, offering effective alternatives to traditional surgical procedures. In 2017, Torax Medical was acquired by Ethicon, a subsidiary of Johnson & Johnson, which expanded Ethicon’s portfolio in the medical device industry.

• Employees 34
• Founded 2002
• Annual Revenue $15860000
• Total Funding $103001497